Biofrontera Inc.

NASDAQ (USD): Biofrontera Inc. (BFRI)

Last Price

0.856

Today's Change

-0.024 (2.72%)

Day's Change

0.821 - 0.91

Trading Volume

708,034

Overview

Market Cap

4 Million

Shares Outstanding

5 Million

Avg Volume

2,583,042

Avg Price (50 Days)

1.06

Avg Price (200 Days)

1.18

PE Ratio

-0.30

EPS

-2.84

Earnings Announcement

13-Nov-2024

Previous Close

0.88

Open

0.91

Day's Range

0.8208 - 0.91

Year Range

0.61 - 4.32

Trading Volume

708,034

Price Change Highlight

1 Day Change

-2.72%

5 Day Change

-11.74%

1 Month Change

7.01%

3 Month Change

-34.65%

6 Month Change

-32.06%

Ytd Change

-69.42%

1 Year Change

-77.65%

3 Year Change

-98.76%

5 Year Change

-99.03%

10 Year Change

-99.03%

Max Change

-99.03%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment